• Home
  • NEW DAY MEDICINE
  • 1 (75) 2025
  • 85 -1 (75) 2025 - Ismatov A.A., Yarbekov R.R. - ISCHEMIC MYTHRAL INSUFFICIENCY: ANALYSIS OF EPIDEMIOLOGICAL AND PROGNOSTIC FACTORS

85 -1 (75) 2025 - Ismatov A.A., Yarbekov R.R. - ISCHEMIC MYTHRAL INSUFFICIENCY: ANALYSIS OF EPIDEMIOLOGICAL AND PROGNOSTIC FACTORS

ISCHEMIC MYTHRAL INSUFFICIENCY: ANALYSIS OF EPIDEMIOLOGICAL AND PROGNOSTIC FACTORS

Ismatov A.A. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Yarbekov R.R. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Teshayev U.Sh. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Muradov M.M. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Akhmedov X.E. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Currently, functional or secondary mitral insufficiency (MI) is the most common acquired heart defect and accounts for a significant proportion of cardiovascular pathology worldwide. The incidence of ischemic mitral regurgitation (IMR), which is one of the complications of ischemic heart disease (IHD), varies from 11 to 59% and develops against the background of acute myocardial infarction (MI). IMR is accompanied by a pronounced clinical picture of heart failure and worsens the prognosis of the disease. The main cause of IMR is changes in the muscle component of the mitral valve associated with myocardial remodeling, which leads to impairment of its functioning. The prognosis of the disease is extremely unfavorable, especially in combination with CHD, with mortality significantly higher than in patients without IMR. Studies show that IMR is a strong predictor of heart failure and increased mortality, making it an important clinical factor. Timely treatment and improved reperfusion can reduce the incidence of CHF and improve patient outcomes, but in the long term, CHF remains a frequent predictor of mortality.

Key words: Ischemic mitral regurgitation, prognosis, coronary artery disease, valve, prognosis, myocardial infarction, heart failure, papillary muscle.

First page

495

Last page

498

For citation:Ismatov A.A., Yarbekov R.R., Teshayev U.Sh., Muradov M.M., Akhmedov X.E. - ISCHEMIC MYTHRAL INSUFFICIENCY: ANALYSIS OF EPIDEMIOLOGICAL AND PROGNOSTIC FACTORS//New Day in Medicine 1(75)2025 495-498 https://https://newdayworldmedicine.com/en/new_day_medicine/1-75-2025

List of References

  1. Asgar A.W., Mack M.J., Stone G.W. Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. //J Am Coll Cardiol. 2015;65(12):1231-1248 PMID: 25814231. https://doi.org/10.1016/j.jacc.
  2. Baumgartner H., Falk V., Bax J.J. et al. ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. //Eur Heart J. 2017;38(36):2739-2791. PMID: 28886619. https://doi.org/10.1093/eurheartj/ehx391
  3. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O'Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb 2;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932. Epub 2020 Dec 17. Erratum in: Circulation. 2021 Feb 2;143(5):e228. doi: 10.1161/CIR.0000000000000960. Erratum in: Circulation. 2021 Mar 9;143(10):e784. doi: 10.1161/CIR.0000000000000966. PMID: 33332149.
  4. Nkomo V.T., Gardin J.M., Skelton T.N., Gottdiener J.S., Scott C.G., Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. //Lancet. 2006;368(9540):1005-1011. PMID: 16980116. https://doi.org/10.1016/S0140-6736(06)69208-8
  5. Dziadzko V, Clavel MA, Dziadzko M, Medina-Inojosa JR, Michelena H, et al. Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet. 2018 Mar 10;391(10124):960-969. doi:10.1016/S0140-6736(18)30473-2. PMID: 29536860; PMCID: PMC5907494.
  6. Kumanohoso T, Otsuji Y, Yoshifuku S, Matsukida K, Koriyama C, Kisanuki A, Minagoe S, Levine RA, Tei C. Mechanism of higher incidence of ischemic mitral regurgitation in patients with inferior myocardial infarction: quantitative analysis of left ventricular and mitral valve geometry in 103 patients with prior myocardial infarction. //J Thorac Cardiovasc Surg. 2003 Jan;125(1):135-43. doi: 10.1067/mtc.2003.78. PMID: 12538997.
  7. Borger MA, Alam A, Murphy PM, Doenst T, David TE. Chronic ischemic mitral regurgitation: repair, replace or rethink? //Ann Thorac Surg. 2006 Mar;81(3):1153-61. doi: 10.1016/j.oathoracsur.2005.08.080. PMID: 16488757.
  8. Gomez-Polo JC, Buzzatti N, Denti P, Gatto P, Scandroglio M, Aiello S, Zangrillo A, Maisano F. Post-infarct mitral insufficiency: when to resort to reparative surgery, when to the mitral clip. //Eur Heart J Suppl. 2022 Nov 12;24(Suppl I):I104-I110. doi: 10.1093/eurheartjsupp/suac082. PMID: 36380806; PMCID: PMC9653122.
  9. Leroux É, Chauvette V, Voisine P, Dagenais F, Charbonneau É, Beaudoin J, Dubois-Sénéchal É, Dubois M, Sénéchal M. Clinical and echocardiographic presentation of postmyocardial infarction papillary muscle rupture. //Echocardiography. 2019 Jul;36(7):1322-1329. doi: 10.1111/echo.14402. Epub 2019 Jun 17. PMID: 31209946.
  10. Carpentier A. Cardiac valve surgery--the "French correction". //J Thorac Cardiovasc Surg. 1983 Sep;86(3):323-37. PMID: 6887954.
  11. Cioffi G., Tarantini L., De Feo S., Pulignano G., Del Sindaco D., Stefenelli C., Di Lenarda A., Opasich C. Functional mitral regurgitation predicts 1-year mortality in elderly patients with systolic chronic heart failure. //Eur J Heart Fail. 2005;7(7):1112-1117. PMID: 15919238. https://doi.org/10.1016/j.ejheart.2005.01.016
  12. Nishino S, Watanabe N, Kimura T, Enriquez-Sarano M, Nakama T, Furugen M, Koiwaya H, Ashikaga K, Kuriyama N, Shibata Y. The Course of Ischemic Mitral Regurgitation in Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention: From Emergency Room to Long-Term Follow-Up. //Circ Cardiovasc Imaging. 2016 Aug;9(8):e004841. doi: 10.1161/CIRCIMAGING.116.004841. PMID: 27516478.
  13. Perl L, Bental T, Orvin K, Vaknin-Assa H, Greenberg G, Codner P, Shapira Y, Vaturi M, Sagie A, Kornowski R. Trends in Ischemic Mitral Regurgitation Following ST-Elevation Myocardial Infarction Over a 20-Year Period. //Front Cardiovasc Med. 2022 Jan 13;8:796041. doi: 10.3389/fcvm.2021.796041. PMID: 35097016; PMCID: PMC8793797.
  14. Lamas GA, Mitchell GF, Flaker GC, Smith SC Jr, Gersh BJ, Basta L, Moyé L, Braunwald E, Pfeffer MA. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. //Circulation. 1997 Aug 5;96(3):827-33. doi: 10.1161/01.cir.96.3.827. PMID: 9264489.

    file

    download